Showing 1 - 10 of 4,963
Persistent link: https://www.econbiz.de/10010345221
This paper aims to analyze the interfaces between Brazilian Competition Law and the issue of access to medicines, with a special focus on abuse of industrial property rights and related exclusionary and exploitative effects. The paper analyzes the case law of Brazilian Administrative Council for...
Persistent link: https://www.econbiz.de/10013365665
Persistent link: https://www.econbiz.de/10002103016
Persistent link: https://www.econbiz.de/10002157797
Persistent link: https://www.econbiz.de/10010202611
This paper analyzes a maximum price system and a reference price system in a vertical differentiation model with a brand-name drug and a generic. In particular, both instruments are compared with respect to their performance in reducing public expenditure, limiting financial exposure of...
Persistent link: https://www.econbiz.de/10010224844
pt. 1. Introduction and conclusion -- pt. 2. Science and precaution in regulatory decision-making -- pt. 3. Regulatory practice : pharmaceuticals, nanotechnology and climate change -- pt. 4. Role of courts -- pt. 5. Role of stakeholders.
Persistent link: https://www.econbiz.de/10014498864
Die Bundesregierung und die Europäische Kommission mussten in den letzten Wochen viel Kritik bezüglich ihrer Impfstoffbeschaffungsstrategie zur Eindämmung der Corona-Pandemie einstecken. Vor dem Hintergrund zu schleppend erscheinender Impfstofflieferungen und der zunehmenden Gefahr durch die...
Persistent link: https://www.econbiz.de/10012434819
This paper analyzes a maximum price system and a reference price system in a vertical differentiation model with a brand-name drug and a generic. In particular, both instruments are compared with respect to their performance in reducing public expenditure, limiting financial exposure of...
Persistent link: https://www.econbiz.de/10014150467